Worth Venture Partners, LLC Puma Biotechnology, Inc. Transaction History

Worth Venture Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $564,186 - $1.3 Million	-197,960 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.63 - $9.39 $421,999 - $597,673	-63,650 Reduced 24.33%	197,960 $1.39 Million
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $312,970 - $404,283	34,852 Added 15.37%	261,610 $2.4 Million
Q1 2021 May 17, 2021	BUY	$9.38 - $13.63 $2.13 Million - $3.09 Million	226,758 New	226,758 $2.2 Million
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $577,821 - $1.18 Million	-27,820 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$20.07 - $46.7 $558,347 - $1.3 Million	27,820 New	27,820 $565,000

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.